Back To: Home : Featured Technology : Flow Cytometry

CLICK HERE FOR WHAT'S NEW IN:
 

IncellDx and Accuri partner on solution for cervical cancer screening
June 2010
SHARING OPTIONS:

MENLO PARK, Calif.IncellDx Inc., a privately held molecular diagnostics company, recently signed a supply agreement with Accuri Cytometers Inc. intended to create an automated, complete solution for cervical cancer screening. The companies' agreement combines new patented technology from IncellDx with the capabilities of the Accuri's C6 Flow Cytometer  

Back


PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.